Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 180
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03649152 | Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan | ||
| NCT03850509 | Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation | ||
| NCT07759544 | I-OPERA: A European Study Testing a New Way to Do Health Research. | ||
| NCT04542057 | A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT02678572 | Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma | ||
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | ||
| NCT03712345 | Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA | ||
| NCT07867886 | An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | ||
| NCT03464019 | Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). | ||
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | ||
| NCT04484935 | Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children | ||
| NCT05731908 | A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | ||
| NCT05508750 | Growth and Safety Clinical Trial on a New Infant Formula | ||
| NCT04699812 | Atrial Fibrillation Algorithms Clinical Validation Study | ||
| NCT02846753 | Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts | ||
| NCT03615924 | Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT03721263 | Study of ASLAN004 in Healthy Subjects | ||
| NCT04540393 | AZD1222 Vaccine for the Prevention of COVID-19 | ||
| NCT05776472 | A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | ||
| NCT05016024 | Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome. | ||
| NCT04720378 | Safety and Tolerability Study of IV ST266 in COVID-19 Subjects | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer | ||
| NCT04091360 | A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease | ||
| NCT07909005 | Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant. | ||
| NCT05985083 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | ||
| NCT05843916 | Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease | ||
| NCT05264506 | Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | ||
| NCT05908084 | To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis | ||
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT05110261 | Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China | ||
| NCT05186324 | Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion | ||
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | ||
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | ||
| NCT07883226 | A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11 | ||
| NCT02374450 | A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine | ||
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT03937479 | Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD | ||
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy | ||
| NCT04247581 | ECG App Algorithms Clinical Validation Study | ||
| NCT02503033 | A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies | ||
| NCT06716801 | Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain | ||
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT03566082 | Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe | ||
| NCT06797258 | FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT05817669 | A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) | ||
| NCT03297281 | Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) |
